Oncolytics Biotech, Inc.
ONCY • NASDAQ
Oncolytics Biotech, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jared Kelly, with a market cap of $130.1M.
Market Cap$130.1M
Employees27.0
CEOJared Kelly
CountryCanada
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · In 2 weeksAfter Market Close · Q1 2026
Financials
Oncolytics Biotech, Inc. FAQ
Common questions about Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026 after market close.
Oncolytics Biotech, Inc. has approximately 27 employees.